U.S. Biotech Stock News

If you are wondering whether Centene's current share price reflects its underlying value, you are not alone. This article will help you frame that question clearly. Centene's stock recently closed at US$46.92, with returns of 14.0% over 7 days, 23.2% over 30 days, 12.3% year to date, but with a 25.7% decline over 1 year, a 40.0% decline over 3 years, and a 27.8% decline over 5 years. These mixed return figures have put renewed attention on how the market is currently assessing managed care...

If you are wondering whether Halliburton’s current share price lines up with its underlying worth, this breakdown will help you see how the numbers stack up. Halliburton shares last closed at US$32.63, with returns of 10.2% over the past week, 12.4% over the last 30 days, 10.2% year to date and 24.6% over the past year, while the 3 year return is an 18.1% decline and the 5 year return is 72.2%. Recent news flow around Halliburton has continued to focus on its role as a major U.S. oilfield...

Knight-Swift Transportation Holdings Inc. has appointed Soumit Roy as executive vice president, General Counsel and Corporate Secretary, effective December 31, 2025, following the retirement of Todd Carlson. The leadership change in the legal and governance function comes as analysts highlight Knight-Swift’s scale, efficiency focus, and exposure to a potential truckload recovery, underscoring the importance of execution and risk management. With analysts increasingly optimistic about a...

Why Stewart Information Services is on investors’ radar With Stewart Information Services (STC) posting annual revenue of US$2,796.513 million and net income of US$101.999 million, investors are weighing how this scale of earnings power lines up with recent share price moves. See our latest analysis for Stewart Information Services. At a share price of US$68.15, Stewart Information Services has experienced short term pressure, with a 1 month share price return of 5.92% and a year to date...

Taylor Morrison Home (TMHC) has just been named America's Most Trusted Home Builder for the eleventh straight year, with its 2026 Net Trust Score improving 5.6 points from 2025. For shareholders, that recognition raises fresh questions about how the company's current valuation lines up with its brand strength and recent share performance. See our latest analysis for Taylor Morrison Home. The trust award comes at a time when Taylor Morrison Home's share price has been relatively firm. A 1-day...

If you are wondering whether Lumentum Holdings still offers good value after its recent strong performance, or if the price has already moved ahead of the underlying story, this article walks through what the current share price might be implying. The stock has pulled back recently, with a 5.5% decline over the last week and a 3.3% decline over the last month. It still shows a 9.8% decline year to date, alongside very large 1 year and multi year returns that may catch your eye. Recent...

BioCryst Pharmaceuticals (BCRX) has drawn investor attention after recent share price moves, with the stock last closing at US$7.62. For a rare disease focused biotech, that puts current performance and ongoing drug development firmly in focus. See our latest analysis for BioCryst Pharmaceuticals. Recent trading has been a bit choppy, with a 1 day share price return of a 3.79% decline and a 7 day share price return of a 2.31% decline, while the 90 day share price return of 5.54% contrasts...

CONMED Corporation recently announced that Chief Financial Officer Todd Garner will step down by March 15, 2026, while staying on as an advisor through November 2, 2026, and at the same time reaffirmed its full-year 2025 consolidated revenue and adjusted EPS guidance originally issued in November 2025. A key detail for investors is that CONMED stated Garner’s planned departure is unrelated to any disagreement over the company’s financial statements or disclosures, aiming to limit concerns...

International Flavors & Fragrances recently reported quarterly revenue of US$2.69 billion, a 7.9% decline year on year, while still exceeding analyst expectations on both organic sales and EBITDA performance. Healthy accounts receivable trends and stable days sales outstanding, alongside an analyst upgrade reflecting increased confidence in the business, highlight that recent operational execution may be more resilient than headline revenue declines suggest. We’ll now examine how this...

In recent days, eBay has faced renewed scrutiny as its active buyer base has remained flat at 134 million for two years, while its EBITDA margin has contracted by 3.5 percentage points and payment processing glitches have frustrated some UK sellers. At the same time, the rapid resale of discontinued New York City MetroCards as collector's items on eBay highlights the platform's enduring role as a marketplace for niche, high-demand memorabilia even as growth and profitability questions...

Cytokinetics recently faced a shareholder rights investigation by Grabar Law Office over allegations that it made misleading statements about the FDA’s review of its aficamten filing, including issues around a potential Risk Evaluation and Mitigation Strategy. This legal scrutiny adds another layer of regulatory and governance risk around aficamten at a time when the company’s late-stage pipeline is central to its outlook. We’ll now examine how this shareholder investigation into disclosures...

What sparked the latest interest in Motorola Solutions stock? Piper Sandler’s recent upgrade of Motorola Solutions (MSI), coupled with positive commentary on its mission critical communications business, has put fresh attention on a stock backed by solid sales growth and strong free cash flow. See our latest analysis for Motorola Solutions. Beyond the analyst upgrade, Motorola Solutions has seen a mixed share price pattern, with a 1-day share price return of 1.17% but a 90-day share price...

If you are wondering whether Topgolf Callaway Brands is attractively priced or not, this article will walk you through what the current share price could imply about value. The stock has been active recently, with a 16.4% return over 7 days, 19.6% over 30 days, 15.9% year to date and 57.2% over the last year, while the 3 year and 5 year returns of 39.0% and 49.8% declines show a very different experience for longer term holders. These recent moves sit against a backdrop of ongoing interest...

If you are wondering whether Allstate's current share price lines up with its underlying worth, you are not alone. That is exactly what this article is here to unpack. Allstate shares last closed at US$211.10, with returns of 1.4% over 7 days, 5.0% over 30 days, 3.6% year to date, 12.2% over 1 year, 65.2% over 3 years and 118.9% over 5 years. This raises fair questions about how much value is now priced in and how much risk investors are taking on at these levels. Recent attention on...

If you are wondering whether MongoDB's share price still reflects good value or has run ahead of itself, looking closely at how it is priced today can help you set expectations before you commit fresh capital. The stock recently closed at US$413.52, with a 1.5% decline over the last 7 days, a roughly flat 0.1% decline over 30 days, and returns of 3.5% year to date and 66.3% over the past year. The 3 year and 5 year returns sit at 116.9% and 13.5% respectively. Recent attention on MongoDB has...

Sidus Space has appointed veteran aerospace and defense executive Kelle Wendling to its Board of Directors, while former members Dana Kilborne and Cole Oliver have concluded their service and Tiffany Norwood has become Chair of the Audit Committee. Wendling’s decades of experience leading complex space systems and government contracting programs at L3Harris bring deep operational and oversight expertise to Sidus Space’s boardroom. With these boardroom shifts and Wendling’s extensive...

If you are wondering whether Costco Wholesale shares still offer good value after a strong multi year run, this article will walk through what the current price tag might really mean for you. The stock most recently closed at US$915.31, with returns of 6.1% over the past 7 days, 3.0% over the past 30 days, 7.1% year to date, and a 0.8% decline over the past year, while the 3 year and 5 year returns sit at 97.7% and 167.0% respectively. Recent coverage of Costco has continued to highlight the...

Wondering if Enterprise Products Partners might still offer value at today’s price, or if the easy gains are behind it? This article walks through what the numbers currently suggest. The unit price recently closed at US$31.86, with returns of a 0.6% decline over 7 days, a 1.5% decline over 30 days, a 0.9% decline year to date, 5.1% over 1 year, 54.0% over 3 years and 99.4% over 5 years. This provides a useful starting point when thinking about value and risk. Recent attention on Enterprise...

Gilat Satellite Networks has confirmed that its CEO Adi Sfadia and CFO Gil Benyamini took part in the 28th Annual Needham Growth Conference in New York on January 13, 2026, hosting a fireside chat and one-on-one investor meetings, with a live webcast and replay available on the company’s investor relations site. This investor outreach comes shortly after Gilat reported third-quarter 2025 earnings ahead of analyst expectations and arranged a US$98.80 million discounted private placement,...

In recent days, Zacks Research upgraded Innospec’s rating from strong sell to hold, Wall Street Zen shifted to a buy rating, and Director Leslie J. Parrette increased his shareholding, lifting insider ownership by 6.19%. Together, these analyst upgrades and insider purchases point to a meaningful shift in external and internal confidence toward Innospec’s outlook. Next, we’ll examine how increased insider ownership could influence Innospec’s investment narrative built around sustainability,...

Celsius Holdings (CELH) has drawn investor attention after recent share price swings, with the stock showing mixed shorter term performance that contrasts with its longer term total returns and current valuation metrics. See our latest analysis for Celsius Holdings. Recent share price moves, including the 12.11% 7 day share price return and 18.68% 30 day share price return from a last close of US$51.28, contrast with the 15.52% 90 day share price decline. At the same time, the 1 year total...

Thermo Fisher Scientific (TMO) has drawn fresh investor attention after enrolling the first patient in its new PPD CorEvitas Obesity Registry, alongside interest in the CEO’s upcoming J.P. Morgan Healthcare Conference appearance and Q4 earnings. See our latest analysis for Thermo Fisher Scientific. Those obesity registry headlines come as Thermo Fisher’s share price sits at US$606.50, with a 7 day share price return of 4.67% and a 90 day share price return of 15.57%. The 1 year total...

What the recent move in OneStream means for investors OneStream (OS) has attracted attention after a recent share move, with the stock up about 28% over the past month and roughly 33% over the past 3 months, prompting fresh questions about valuation. See our latest analysis for OneStream. Zooming out, OneStream’s recent surge sits against a mixed backdrop, with a 90 day share price return of 33.18% alongside a 1 year total shareholder return decline of 10.47%. This suggests momentum has...

If you are wondering whether Abercrombie & Fitch at around US$129.85 is still a sensible entry point or already pricing in the story, you are not alone. The stock has recently seen a 3.2% return over the last 7 days, 29.9% over the last 30 days, 4.9% year to date, a 14.4% decline over the last year, and a very large 3 year and 5 year return that is more than 4x the starting level. Recent coverage has focused on Abercrombie & Fitch as a retailer that has been back in the spotlight, with...